# Efficacy Confirmation Trial of CDP870 Without Coadministration of Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA)

> **NCT00791921** · PHASE3 · COMPLETED · sponsor: **Otsuka Pharmaceutical Co., Ltd.** · enrollment: 230 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** CDP870
- **DRUG:** Placebo of CDP870

## Key facts

- **NCT ID:** NCT00791921
- **Lead sponsor:** Otsuka Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 230 (ACTUAL)
- **Last updated:** 2012-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00791921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00791921, "Efficacy Confirmation Trial of CDP870 Without Coadministration of Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA)". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00791921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*